Cala Health Gains FDA Clearance for kIQ Plus Device
San Mateo, California & Chicago, Illinois, U.S. | April 15, 2026 Cala Health has announced a major regulatory milestone...
Neuromodulation
Advertisement
BrainsWay FDA Approval Expands Depression Treatment Access
BURLINGTON, Mass. and JERUSALEM, March 31, 2026 BrainsWay Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
Nyxoah Expands Genio Sleep Apnea Therapy Access
Middle East Partnership Advances Neurostimulation Care – February 18, 2026 | Mont-Saint-Guibert, Belgium Nyxoah has signed a Memorandum of...
CVRx Secures Category I CPT Codes for Barostim Therapy
MINNEAPOLIS | January 6, 2026 — CVRx, Inc. has announced the implementation of new Category I Current Procedural Terminology...
ONWARD Medical Advances ARC-EX Technology with Strong Q3 Achievements
Eindhoven, Netherlands — Nov. 24, 2025 — ONWARD Medical N.V. announced a series of major scientific, regulatory, and commercial...
Advertisements
NeuroSigma Study Reveals Real-Time Brain Effects of eTNS
Los Angeles, California – November 3, 2025 NeuroSigma, Inc., a Los Angeles-based bioelectronics company, has announced a groundbreaking publication...
Advertisement
